Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GABA analog prodrug sustained release oral dosage forms

GABA analog prodrug sustained release oral dosage forms

US Patent 9949941 · Granted Apr 24, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic peptides2023
Peptide-containing formulations2022
Combination dosage form of a mu opioid receptor antagonist and an opioid agent2022
Therapeutic peptides2022
Therapeutic peptides2021
Methods of administering monomethyl fumarate and prodrugs thereof having reduced2021
Combination dosage form of a mu opioid receptor antagonist and an opioid agent2021
Combination dosage form of a mu opioid receptor antagonist and an opioid agent2019
Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of 2015
GABA analog prodrug sustained release oral dosage forms2014
GABA analog prodrug sustained release oral dosage forms2014
GABA analog prodrug sustained release oral dosage forms2014